Celgene Corp. buy tamam
Start price
19.03.17
/
50%
€113.26
Target price
12.11.18
€127.22
Performance (%)
-41.19%
End price
12.11.18
€66.61
Summary
This prediction ended on 12.11.18 with a price of €66.61. The BUY prediction by tamam for Celgene Corp. performed very badly with a performance of -41.19%. tamam has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Celgene Corp. | - | - | - | - |
| iShares Core DAX® | -1,86 % | 0,67 % | 0,92 % | 51,85 % |
| iShares Nasdaq 100 | -3,32 % | 4,99 % | 33,72 % | 86,85 % |
| iShares Nikkei 225® | -2,30 % | 6,13 % | 52,96 % | 63,32 % |
| iShares S&P 500 | -1,31 % | 3,40 % | 24,67 % | 66,11 % |
Comments by tamam for this prediction
In the thread Celgene Corp. diskutieren
Celgene is a true "buy & hold" name in the biotech sector
tamam stimmt am 19.03.2017 der Outperform-Einschätzung der institutionellen Analysten mit dem Kursziel 141.04$ zu.
(Vom Mitglied beendet)